Abstract:Congenital myasthenia syndromes (CMS) are caused by genetic defects that impair neuromuscular transmission. Efficient synaptic transmission at the neuromuscular junction (NMJ) incorporates many different proteins involved both in the signal transmission itself and in generating the prerequisite specialized synaptic structures. As a consequence, there are multiple pathogenic mechanisms that can underlie CMS. A recent comprehensive review of CMS highlights many of these mechanisms [1▪▪] . There are currently 35 genes reported to be associated with CMS (Fig. 1 and Table 1). The prevalence reported varies considerably between regions, 2.8–14.8 per million (UK), 1.8 per million (Brazil), and 22.2 per million (Slovenia) [2] . Differences are likely to occur because of mutation founder effects in certain regions and historically because of different pick-up rates as new detection technologies are adopted. The clinical use of next-generation sequencing greatly facilitates detection of mutations in larger genes, such as AGRN , LRP4 , MUSK , COLQ , and thus increases in reported prevalence is likely to continue [3–7] . Whilst symptom onset at birth or infancy is the commonest presentation, later onset in childhood and adult life is now increasingly recognized. The clinical phenotypes can vary in the subtypes, but the hallmark is fatigable weakness predominantly affecting axial and proximal limb muscle, ocular, bulbar and or respiratory involvement. A suspected diagnosis is based on typical clinical features, decremental responses of 10% or more on repetitive nerve stimulation (RNS) and/or abnormal jitter and block on single-fibre EMG. It is prudent to note that RNS may show incremental response on high-frequency stimulation in some presynaptic (VAMP1, UNC13A, SYT2, RPH3A) and one synaptic (LAMA5) CMS subtype [8,9] . The inheritance patten in CMS is autosomal recessive except for dominant pattern seen in slow channel syndromes, SNAP25, PURA and some SYT2 patients [1▪▪] . Here, we highlight the widening phenotype spectrum associated with gene mutations that can not only have an effect of the NMJ but also show systemic and brain involvement (Table 2), and on current and emerging therapeutic strategies for CMS.

Limb-Girdle Congenital Myasthenic Syndrome in A Chinese Family with Novel Mutations in Musk Gene and Literature Review

Congenital myasthenia syndrome in a Chinese family with mutations in MUSK: A hotspot mutation and literature review.

Novel Mutations in the C-terminal Region of GMPPB Causing Limb-Girdle Muscular Dystrophy Overlapping with Congenital Myasthenic Syndrome

Novel compound missense variants in MUSK impair LRP4-MUSK-DOK7 complex associated with congenital myasthenic syndrome 9 and insights into genotype-phenotype correlation

A Novel Mutation of LRSAM1 in a Chinese Family with Charcot-Marie-Tooth Disease

Abnormal decrement on high-frequency repetitive nerve stimulation in congenital myasthenic syndrome with GFPT1 mutations and review of literature

Clinical Features and Molecular Genetic Analysis of a Pedigree of Limb Girdle Muscular Dystrophy

Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review

CHRNB1 Gene Mutations-Related Congenital Myasthenic Syndromes in a Chinese Family

Congenital myasthenic syndromes: increasingly complex

Limb Girdle Muscular Dystrophy 23 Caused by Compound Heterozygous Mutations of LAMA2 Gene

Clinical features of the myasthenic syndrome arising from mutations in GMPPB

[Clinical, Molecular Pathological and Genetic Analyses of a Chinese Family with Congenital Muscular Dystrophy Type 1A].

Genetic analysis of a family affected by congenital myasthenic syndrome due to a Novel mutation in the SLC5A7 gene

Two Patients with Congenital Myasthenic Syndrome Caused by COLQ Gene Mutations and the Consequent ColQ Protein Defect.

Clinical, Myopathological and Genetic Mutations Features of Limb Girdle Muscular Dystrophy 2I

Diverse myopathological features in the congenital myasthenia syndrome with GFPT1 mutation

First familial limb-girdle muscular dystrophy 2L in China: Clinical, imaging, pathological, and genetic features.

A spontaneous missense mutation in the chromodomain helicase DNA-binding protein 8 (CHD8) gene: a novel association with congenital myasthenic syndrome

The severity of MUSK pathogenic variants is predicted by the protein domain they disrupt

Clinical spectrum and genetic variations of <i>LMNA</i>-related muscular dystrophies in a large cohort of Chinese patients